WallStreetZenWallStreetZen

NASDAQ: ADMP
Adamis Pharmaceuticals Corp Earnings & Revenue

OverviewEarnings
DividendOwnership

ADMP past revenue growth

How has ADMP's revenue growth performed historically?
Company
115.34%
Industry
255.23%
Market
17.24%
ADMP's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ADMP's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ADMP's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ADMP earnings and revenue history

Current Revenue
$4.8M
Current Earnings
-$26.5M
Current Profit Margin
-556.7%

ADMP Return on Equity

Current Company
-424%
Current Industry
9.1%
Current Market
188%
ADMP's Return on Equity (-424%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ADMP announces earnings.

ADMP Return on Assets

Current Company
-148.5%
Current Industry
4.4%
ADMP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ADMP Return on Capital Employed

Current Company
5,702.99%
Current Industry
10.2%
ADMP has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ADMP vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ADMP$4.76M-$25.04M-$26.48M-18.31%N/A
CLVR$17.80M-$66.02M-$66.17M+108.35%N/A
SBFM$490.88k-$2.51M-$2.57M+52.33%N/A
BFRI$28.67M$759.00k-$640.00k+45.66%N/A
LCI$308.52M-$105.90M-$192.52M-13.58%N/A
View Top Pharmaceutical Stocks

ADMP earnings dates

Next earnings date
May 15, 2023

Adamis Pharmaceuticals Earnings & Revenue FAQ

What were ADMP's earnings last quarter?

On Invalid Date, Adamis Pharmaceuticals (NASDAQ: ADMP) reported Q4 2022 earnings per share (EPS) of -$0.03, up 50% year over year. Total Adamis Pharmaceuticals earnings for the quarter were -$3.33 million. In the same quarter last year, Adamis Pharmaceuticals's earnings per share (EPS) was -$0.06.

If you're new to stock investing, here's how to buy Adamis Pharmaceuticals stock.

What was ADMP's earnings growth in the past year?

As of Q2 2023, Adamis Pharmaceuticals's earnings has grown year over year. Adamis Pharmaceuticals's earnings in the past year totalled -$26.48 million.

What is ADMP's earnings date?

Adamis Pharmaceuticals's earnings date is Invalid Date. Add ADMP to your watchlist to be reminded of ADMP's next earnings announcement.

What was ADMP's revenue last quarter?

On Invalid Date, Adamis Pharmaceuticals (NASDAQ: ADMP) reported Q4 2022 revenue of $2.15 million up 285.49% year over year. In the same quarter last year, Adamis Pharmaceuticals's revenue was -$1.16 million.

What was ADMP's revenue growth in the past year?

As of Q2 2023, Adamis Pharmaceuticals's revenue has grown 115.34% year over year. This is 139.89 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 255.23%. Adamis Pharmaceuticals's revenue in the past year totalled $4.76 million.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.